HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation.

AbstractBACKGROUND:
In vitro evidence suggests that the p38 mitogen-activated protein kinase (p38 MAPK) plays a crucial role in PMN activation and inflammatory cytokine production. However, the effect of p38 MAPK on myocardial reperfusion injury, a pathologic condition involving a typical inflammatory response, has not been fully examined. In the present study, we investigated the effect of SB 239063, a specific p38 MAPK inhibitor, on myocardial injury in a murine ischemia/reperfusion (I/R) model and elucidated the mechanism by which p38 MAPK inhibitor may exert its protective effect against I/R injury.
METHODS AND RESULTS:
I/R resulted in a significant myocardial injury (myocardial infarct 45 +/- 2.9%) and marked PMN accumulation (myeloperoxidase activity 1.03 +/- 0.16 U/100 g tissue). Administration of SB 239063 significantly inhibited the myocardial inflammatory response as evidenced by reduced PMN accumulation in I/R myocardial tissue (0.62 +/- 0.008 U/100 g tissue, P<0.01 vs. vehicle), and markedly attenuated myocardial reperfusion injury (myocardial infarct size: 28 +/- 2.4%, P<0.01 vs. vehicle). Moreover, treatment with SB 239063 significantly attenuated I/R-induced P-selectin and ICAM-1 upregulation (13.8 +/- 2.7 vs. 23.9 +/- 3.1%, and 29.4 +/- 1.6 vs. 56.3 +/- 4.8%, respectively P<0.01). In addition, pre-treatment with R15.7, a monoclonal antibody against CD 18 adhesion molecule on PMN surface that virtually abolished PMN accumulation in ischemic-reperfused myocardial tissue, significantly, but not completely, blocked the cardioprotection exerted by SB 239063.
CONCLUSION:
These results demonstrated for the first time that p38 MAPK activation plays a significant role in adhesion molecule upregulation on ischemia-reperfused endothelial cells and is an important signaling step in the pathogenesis of PMN-mediated tissue injury.
AuthorsFeng Gao, Tian-Li Yue, Dong-Wei Shi, Theodore A Christopher, Bernard L Lopez, Eliot H Ohlstein, Frank C Barone, Xin L Ma
JournalCardiovascular research (Cardiovasc Res) Vol. 53 Issue 2 Pg. 414-22 (Feb 01 2002) ISSN: 0008-6363 [Print] England
PMID11827692 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Imidazoles
  • P-Selectin
  • Pyrimidines
  • Intercellular Adhesion Molecule-1
  • Peroxidase
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • SB 239063
Topics
  • Analysis of Variance
  • Animals
  • Endothelium, Vascular (metabolism)
  • Imidazoles (pharmacology)
  • Intercellular Adhesion Molecule-1 (analysis)
  • Male
  • Mitogen-Activated Protein Kinases (analysis, antagonists & inhibitors)
  • Myocardial Infarction (metabolism)
  • Myocardial Reperfusion Injury (immunology, prevention & control)
  • Neutrophils (physiology)
  • P-Selectin (analysis)
  • Peroxidase (analysis)
  • Pyrimidines (pharmacology)
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction
  • p38 Mitogen-Activated Protein Kinases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: